← Back to Search
Third-generation Immucillins: Syntheses And Bioactivities Of Acyclic Immucillin Inhibitors Of Human Purine Nucleoside Phosphorylase.
K. Clinch, G. B. Evans, Richard F. G. Fröhlich, R. Furneaux, P. Kelly, Laurent Legentil, A. S. Murkin, L. Li, V. Schramm, P. Tyler, A. D. Woolhouse
Published 2009 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
ImmH (1) and DADMe-ImmH (2) are potent inhibitors of human purine nucleoside phoshorylase (PNP), developed by us and currently in clinical trials for the treatment of a variety of T-cell related diseases. Compounds 1 and 2 were used as templates for the design and synthesis of a series of acyclic immucillin analogues (8-38) in order to identify simplified alternatives to 1 and 2. SerMe-ImmG (8) and DATMe-ImmG (9) displayed the lowest inhibition constants of 2.1 and 3.4 pM, respectively, vs PNP. It was postulated that the flexible natures of 8 and 9 enabled them to adopt conformations resembling those of 1 and 2 within the active site of PNP and that the positioning of two hydroxyl groups was critical for picomolar activity. SerMe-ImmH (10, K(d) = 5.2 pM) was shown to be orally available in mice with a long biological residence time on blood PNP.
This paper references
Synthesis of second-generation transition state analogues of human purine nucleoside phosphorylase.
G. B. Evans (2003)
Transition state analysis for human and Plasmodium falciparum purine nucleoside phosphorylases.
A. Lewandowicz (2004)
Simplified analogues of immucillin-G retain potent human purine nucleoside phosphorylase inhibitory activity.
Teresa Semeraro (2006)
Synthesis of "9-deazaguanosine" and other new pyrrolo[3,2-d]pyrimidine C-nucleosides
M. I. Lim (1983)
Neighboring group participation in the transition state of human purine nucleoside phosphorylase.
A. S. Murkin (2007)
The acyclic nucleoside phosphonates from inception to clinical use: historical perspective.
E. Clercq (2007)
Transition state analogue discrimination by related purine nucleoside phosphorylases.
Erika A Taylor Ringia (2006)
An Improved Preparation of the Activity-Based Probe JPM-OEt and In Situ Applications
K. Chehade (2005)
A Practical Synthesis of Nelfinavir, an HIV-Protease Inhibitor, Using a Novel Chiral C4 Building Block: (5R,6S)-2,2-Dimethyl-5-hydroxy-1,3-dioxepan-6-ylammonium Acetate
Takashi Inaba (1998)
Acyclic and cyclopropyl analogues of adenosine bisphosphate antagonists of the P2Y1 receptor: structure-activity relationships and receptor docking.
H. S. Kim (2001)
Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation.
B. Xu (2002)
Forodesine, an inhibitor of purine nucleoside phosphorylase, induces apoptosis in chronic lymphocytic leukemia cells.
K. Balakrishnan (2006)
Acyclovir: Discovery, mechanism of action, and selectivity
G. Elion (1993)
Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase.
G. B. Evans (2003)
Synthesis of new tridentate chiral aminoalcohols by a multicomponent reaction and their evaluation as ligands for catalytic asymmetric Strecker reaction
Vorawit Banphavichit (2007)
Transition states and inhibitors of the purine nucleoside phosphorylase family.
Erika A Taylor Ringia (2005)
One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.
R. W. Miles (1998)
Stereocontrolled syntheses of carbocyclic C-nucleosides and related compounds.
B. K. Chun (2001)
A highly efficient organocatalyst for direct aldol reactions of ketones with aldehydes [corrected].
Z. Tang (2005)
A straightforward synthesis of L-isoserinal
F. Junquera (1996)
Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes
G. Kicska (2001)
Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.
T. Robak (2006)
Acyclic ribooxacarbenium ion mimics as transition state analogues of human and malarial purine nucleoside phosphorylases.
E. A. Taylor (2007)
Systemic monotherapy vs combination therapy for CTCL: rationale and future strategies.
M. Duvic (2007)
Achieving the Ultimate Physiological Goal in Transition State Analogue Inhibitors for Purine Nucleoside Phosphorylase*
A. Lewandowicz (2003)
Enzymatic Transition State Theory and Transition State Analogue Design*
V. Schramm (2007)
Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.
G. B. Elion (1977)
NUCLEOSIDE-PHOSPHORYLASE DEFICIENCY IN A CHILD WITH SEVERELY DEFECTIVE T-CELL IMMUNITY AND NORMAL B-CELL IMMUNITY
EloiseR. Giblett (1975)
V. Schramm (2003)
Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphoma
F. Ravandi (2006)
A synthetic route to 9-(polyhydroxyalkyl)purines.
D. Horton (2006)
Synthesis of a transition state analogue inhibitor of purine nucleoside phosphorylase via the Mannich reaction.
G. B. Evans (2003)
Enzymatic transition states: thermodynamics, dynamics and analogue design.
V. Schramm (2005)
Drug evaluation: forodesine - PNP inhibitor for the treatment of leukemia, lymphoma and solid tumor.
C. Galmarini (2006)
Energetic Mapping of Transition State Analogue Interactions with Human and Plasmodium falciparum Purine Nucleoside Phosphorylases*♦
A. Lewandowicz (2005)
Azetidine based transition state analogue inhibitors of N-ribosyl hydrolases and phosphorylases.
G. B. Evans (2008)
The synthesis and antiviral properties of acyclic nucleoside analogues with a phosphonomethoxy fragment in the side chain.
A. Khandazhinskaya (2006)
Mixed solvents containing methanol as useful reaction media for unique chemoselective reductions within lithium borohydride
K. Soai (1986)
Formal Synthesis of a 2- and 8-Functionalized 1,4,7-Trioxa-10-azaspiro[5.5]undecane
M. Lemaire (1995)
This paper is referenced by
Therapeutic applications of iminosugars: current perspectives and future opportunities.
G. Horne (2011)
Intracellular rebinding of transition-state analogues provides extended in vivo inhibition lifetimes on human purine nucleoside phosphorylase
Sara T. Gebre (2017)
Crystal structure of Schistosoma purine nucleoside phosphorylase complexed with a novel monocyclic inhibitor.
Humberto M Pereira (2010)
Selective functionalization of the primary hydroxy group in triols
G. Z. Raskil’dina (2015)
Purine nucleoside phosphorylase from Schistosoma mansoni in complex with ribose-1-phosphate
Humberto D'Muniz Pereira (2011)
New Antibiotic Candidates against Helicobacter pylori.
Shanzhi Wang (2015)
Origin of Enzymatic Kinetic Isotope Effects in Human Purine Nucleoside Phosphorylase
M. Roca (2017)
Effect of different reaction conditions on the structural diversity of zinc(II) complexes with 9-deazahypoxanthine
J. Gáliková (2014)
Synthetic Entries to and Biological Activity of Pyrrolopyrimidines.
Laurens M De Coen (2016)
Adenosine binding to low-molecular-weight purine nucleoside phosphorylase: the structural basis for recognition based on its complex with the enzyme from Schistosoma mansoni.
H. Pereira (2010)
Synthesis and evaluation of eight- and four-membered iminosugar analogues as inhibitors of testicular ceramide-specific glucosyltransferase, testicular β-glucosidase 2, and other glycosidases.
J. C. Lee (2012)
Trimeric purine nucleoside phosphorylase: exploring postulated one-third-of-the-sites binding in the transition state.
B. Wielgus-Kutrowska (2012)
Nucleoside Hydrolase NH 36: A Vital Enzyme for the Leishmania Genus in the Development of T-Cell Epitope Cross-Protective Vaccines
C. B. Palatnik-de-Sousa (2019)
Graeme J. Gainsford (2010)
The synthesis of possible transition state analogue inhibitors of thymidine phosphorylase
G. B. Evans (2015)
Mannich bases in medicinal chemistry and drug design
G. Roman (2015)
The synthesis of piperidine nucleoside analogs—a comparison of several methods to access the introduction of nucleobases
Soňa Kovačková (2011)
Transition state analogue inhibitors of human methylthioadenosine phosphorylase and bacterial methylthioadenosine/S-adenosylhomocysteine nucleosidase incorporating acyclic ribooxacarbenium ion mimics.
K. Clinch (2012)
Synthesis, X-ray crystal structure and biological evaluation of zinc(II)-dichlorido complexes with 9-deazahypoxathine derivatives
J. Gáliková (2015)
Structural basis for selective inhibition of purine nucleoside phosphorylase from Schistosoma mansoni: kinetic and structural studies.
M. Castilho (2010)
Plasmodium Purine Metabolism and Its Inhibition by Nucleoside and Nucleotide Analogues.
Thomas Cheviet (2019)
Guanosine negatively modulates the gastric motor function in mouse
Maria Grazia Zizzo (2013)
New function for Escherichia coli xanthosine phophorylase (xapA): genetic and biochemical evidences on its participation in NAD+ salvage from nicotinamide
Wei-Ren Dong (2013)
Structure-activity relationship study of selective excitatory amino acid transporter subtype 1 (EAAT1) inhibitor 2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (UCPH-101) and absolute configurational assignment using infrared and vibrational circu
Tri H V Huynh (2012)
Pontifícia Universidade Católica do Rio Grande do Sul Programa de Pós-Graduação em Biologia Celular e Molecular
Leonardo Krás (2011)
Oligonucleotide transition state analogues of saporin L3.
Jennifer M. Mason (2017)
Design, synthesis and immunomodulating activity of C-pseudonucleosides containing thiazolidin-4-one and phenyl connected by acetamide bond
H. Chen (2016)
Four generations of transition-state analogues for human purine nucleoside phosphorylase
Meng-Chiao Ho (2010)
Synthesis of nucleoside phosphonate analogs having phosphonodifluoromethylene moieties and their biological activities
Guang Huan Shen (2019)
Design of novel potent inhibitors of human uridine phosphorylase-1: synthesis, inhibition studies, thermodynamics, and in vitro influence on 5-fluorouracil cytotoxicity.
Daiana Renck (2013)
A Pipeline To Enhance Ligand Virtual Screening: Integrating Molecular Dynamics and Fingerprints for Ligand and Proteins
Francesca Spyrakis (2015)
Design and divergent synthesis of aza nucleosides from a chiral imino sugar.
Saúl Martínez-Montero (2012)See more